Innate Antiviral Response: Role in HIV-1 Infection

被引:25
作者
Pitha, Paula M. [1 ,2 ,3 ]
机构
[1] Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21231 USA
[2] Johns Hopkins Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA
来源
VIRUSES-BASEL | 2011年 / 3卷 / 07期
关键词
virus; HIV-1; interferon; IRF; innate immune response; INTERFERON REGULATORY FACTOR; VIRUS TYPE-1 INFECTION; NF-KAPPA-B; TOLL-LIKE RECEPTORS; RIG-I; TRANSCRIPTIONAL ACTIVITY; DENDRITIC CELLS; FACTOR FAMILY; ACCESSORY PROTEINS; UBIQUITIN LIGASE;
D O I
10.3390/v3071179
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
As an early response to infection, cells induce a profile of the early inflammatory proteins including antiviral cytokines and chemokines. Two families of transcriptional factors play a major role in the transcriptional activation of the early inflammatory genes: The well-characterized family of NFkB factors and the family of interferon regulatory factors (IRF). The IRFs play a critical role in the induction of type I interferon (IFN) and chemokine genes, as well as genes mediating antiviral, antibacterial, and inflammatory responses. Type I IFNs represent critical components of innate antiviral immunity. These proteins not only exert direct antiviral effects, but also induce maturation of dendritic cells (DC), and enhance functions of NK, T and B cells, and macrophages. This review will summarize the current knowledge of the mechanisms leading to the innate antiviral response with a focus on its role in the regulation of HIV-1 infection and pathogenicity. We would like this review to be both historical and a future perspective.
引用
收藏
页码:1179 / 1203
页数:25
相关论文
共 162 条
  • [41] Expression, purification, and co-crystallization of IRF-I bound to the interferon-beta element PRDI
    Escalante, CR
    Yie, JM
    Thanos, D
    Aggarwal, AK
    [J]. FEBS LETTERS, 1997, 414 (02) : 219 - 220
  • [42] IKKε and TBK1 are essential components of the IRF3 signaling pathway
    Fitzgerald, KA
    McWhirter, SM
    Faia, KL
    Rowe, DC
    Latz, E
    Golenbock, DT
    Coyle, AJ
    Liao, SM
    Maniatis, T
    [J]. NATURE IMMUNOLOGY, 2003, 4 (05) : 491 - 496
  • [43] Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction
    Fitzgerald, KA
    Palsson-McDermott, EM
    Bowie, AG
    Jefferies, CA
    Mansell, AS
    Brady, G
    Brint, E
    Dunne, A
    Gray, P
    Harte, MT
    McMurray, D
    Smith, DE
    Sims, JE
    Bird, TA
    O'Neill, LAJ
    [J]. NATURE, 2001, 413 (6851) : 78 - 83
  • [44] LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF
    Fitzgerald, KA
    Rowe, DC
    Barnes, BJ
    Caffrey, DR
    Visintin, A
    Latz, E
    Monks, B
    Pitha, PM
    Golenbock, DT
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (07) : 1043 - 1055
  • [45] Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor confers resistance to the antiproliferative effect of interferon-α
    Flowers, CC
    Flowers, SP
    Nabel, GJ
    [J]. MOLECULAR MEDICINE, 1998, 4 (06) : 402 - 412
  • [46] EVIDENCE FOR A NUCLEAR FACTOR(S), IRF-1, MEDIATING INDUCTION AND SILENCING PROPERTIES TO HUMAN IFN-BETA GENE REGULATORY ELEMENTS
    FUJITA, T
    SAKAKIBARA, J
    SUDO, Y
    MIYAMOTO, M
    KIMURA, Y
    TANIGUCHI, T
    [J]. EMBO JOURNAL, 1988, 7 (11) : 3397 - 3405
  • [47] TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity
    Gack, Michaela U.
    Shin, Young C.
    Joo, Chul-Hyun
    Urano, Tomohiko
    Liang, Chengyu
    Sun, Lijun
    Takeuchi, Osamu
    Akira, Shizuo
    Chen, Zhijian
    Inoue, Satoshi
    Jung, Jae U.
    [J]. NATURE, 2007, 446 (7138) : 916 - U2
  • [48] KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway
    Gao, SJ
    Boshoff, C
    Jayachandra, S
    Weiss, RA
    Chang, Y
    Moore, PS
    [J]. ONCOGENE, 1997, 15 (16) : 1979 - 1985
  • [49] Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod
    Gibson, SJ
    Lindh, JM
    Riter, TR
    Gleason, RM
    Rogers, LM
    Fuller, AE
    Oesterich, JL
    Gorden, KB
    Qiu, XH
    McKane, SW
    Noelle, RJ
    Miller, RL
    Kedl, RM
    Fitzgerald-Bocarsly, P
    Tomai, MA
    Vasilakos, JP
    [J]. CELLULAR IMMUNOLOGY, 2002, 218 (1-2) : 74 - 86
  • [50] HIV-1 Antagonism of CD317 Is Species Specific and Involves Vpu-Mediated Proteasomal Degradation of the Restriction Factor
    Goffinet, Christine
    Allespach, Ina
    Homann, Stefanie
    Tervo, Hanna-Mari
    Habermann, Anja
    Rupp, Daniel
    Oberbremer, Lena
    Kern, Christian
    Tibroni, Nadine
    Welsch, Sonja
    Krijnse-Locker, Jacomine
    Banting, George
    Kraeusslich, Hans-Georg
    Fackler, Oliver T.
    Keppler, Oliver T.
    [J]. CELL HOST & MICROBE, 2009, 5 (03) : 285 - 297